UK markets closed

Vaxart, Inc. (VXRT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
7.68+0.13 (+1.79%)
As of 01:29PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close7.55
Bid7.66 x 800
Ask7.67 x 800
Day's range7.51 - 8.13
52-week range4.86 - 24.90
Avg. volume3,439,041
Market cap964.437M
Beta (5Y monthly)0.35
PE ratio (TTM)N/A
EPS (TTM)-0.54
Earnings date23 Feb 2022 - 28 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend date09 Nov 2012
1y target est13.00
  • Motley Fool

    3 Vaccine Latecomers That Could Double Your Money

    Experts predict the coronavirus will stick around -- so a potential end to the pandemic wouldn't necessarily equal an end to the need for vaccination. In fact, you may see bigger returns from an investment in a smaller biotech company that hasn't yet reached the vaccine finish line. Positive clinical trial reports or regulatory submissions could be major catalysts.

  • Motley Fool

    3 COVID Pill Stocks That Might Be Game-Changers

    Despite the tremendous success of vaccines against the coronavirus, there's always more work to be done when it comes to reducing the risks associated with infection. If coronavirus vaccine development was the story of 2020, antiviral pill development might well be the story of 2021 and 2022. Pfizer (NYSE: PFE) is currently working on an antiviral pill for COVID-19 to add to its profitable coronavirus portfolio, where its highly successful vaccine is front and center.

  • Zacks

    VAXART, INC. (VXRT) Reports Q3 Loss, Lags Revenue Estimates

    VAXART, INC. (VXRT) delivered earnings and revenue surprises of 6.67% and -9.91%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?